CD93 and allergic asthma: Further investigations by Park et al. using mouse models of acute asthma and lipopolysaccharide-induced airway inflammation revealed a decrease in CD93 levels in lung homogenates and respiratory epithelial cells, alongside an increase in serum sCD93 levels, reinforcing the potential of sCD93 as a biomarker for allergic asthma [122].